Healthcare Industry News: Elekta
News Release - July 30, 2012
Elekta to Incorporate Brainlab Patient Positioning Technology in Therapy Systems to Increase Comfort for Patients with CancerIndia’s Fortis Healthcare will be first installation of Elekta treatment systems equipped with Brainlab’s ExacTrac patient positioning system
STOCKHOLM--(Healthcare Sales & Marketing Network)--Elekta (STO:EKTAB) announced that collaboration with Brainlab has resulted in the integration of Brainlab’s ExacTrac® patient positioning system in its Elekta radiation therapy machines. Two Elekta systems fitted with ExacTrac are scheduled to be installed at Fortis Healthcare, a leading hospital chain in India and nine other countries.
ExacTrac is a reliable, field-proven system for supporting accurate frameless SRT for patients with tumors of the brain, spine and other anatomy. Offering sub-millimeter precision, ExacTrac provides exceptional accuracy during the entire SRT procedure and helps to reduce errors within the process, thereby maximizing overall treatment accuracy. By providing the option of non-invasive frameless SRT, physicians are also able to offer patients a better treatment experience, increasing comfort and reducing anxiety.
“Integrating best-of-breed technologies in our solutions is in complete harmony with Elekta’s open systems philosophy, and gives both Brainlab and Elekta customers access to both companies’ technologies to improve their SRT capabilities,” says Bill Yaeger, Executive Vice President, Elekta Oncology.
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 15:30 CET on July 30, 2012.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.Elekta.com.
Brainlab develops, manufactures and markets software-driven medical technology with the aim of optimizing patient treatments. Core products revolve around less-invasive image guided surgery technology, more accurate and effective radiation therapy, and integration through planning and collaboration systems that brings patient data and physicians together. www.brainlab.com
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.